Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 15 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Bone Morphogenetic Proteins [Clear All Filters]
(2018).
(2017).
(2017).
Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Investigational drugs for fracture healing: preclinical & clinical data..
Expert Opin Investig Drugs. 25(5), 585-96.
(2016). Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation..
Rheumatology (Oxford). 54(5), 908-14.
(2015). Denosumab versus zoledronic acid in patients previously treated with zoledronic acid..
Osteoporos Int. 26(10), 2521-7.
(2015). The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea..
J Clin Endocrinol Metab. 99(11), E2252-8.
(2014). Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial..
J Clin Endocrinol Metab. 98(8), 3206-12.
(2013). Serum sclerostin levels following treatment with parathyroid hormone..
J Endocrinol Invest. 36(4), 280.
(2013).
(2012).
(2012).
Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge..
Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
(2011). Is there a role for bone morphogenetic proteins in osteoporotic fractures?.
Injury. 40 Suppl 3, S21-6.
(2009). Bone morphogenetic protein expression in newborn rat kidneys after prenatal exposure to radiofrequency radiation..
Bioelectromagnetics. 25(3), 216-27.
(2004).